GlassScriptPhysician profile
Laura Anne Fox
NPI 1902431422
$1,630.88
in general payments reported to CMS, 2019-2025
12 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.00 · 2022: $151 · 2023: $602 · 2024: $521 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,215.17 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System, Minimed 770g |
| Novo Nordisk INC | $95.65 | 2022-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.24 | 2021-2025 | Jardiance |
| Abbott Laboratories | $42.86 | 2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $41.41 | 2025 | Zepbound, Mounjaro |
| Antares Pharma, INC. | $37.63 | 2022-2023 | Tlando, Nocdurna, Xyosted |
| Amgen INC. | $32.05 | 2024-2025 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $31.43 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $24.70 | 2024 | Recorlev |
| Corcept Therapeutics | $24.65 | 2025 | Korlym |
| Ascendis Pharma Endocrinology INC | $20.79 | 2025 | Yorvipath |
| Tandem Diabetes Care, INC. | $19.30 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.